MétaCan
Menu
Cohort builder

4,299,418 works, Canadian by any of four routes.

Every filter state is a URL; the URL is the query; the query is citable via /q/⟨hash⟩. The page, the API and the export parse the same parameters.

The current cohort, streamed from the database: every work column, the machine labels, the provisional scores, and the per-row validation status. Exports are capped at 100,000 rows. Mints a permanent /q/ link for this exact query. The same filters always produce the same link, whoever asks.

Search term
Author
Year range
Sort
Language
Type
Field
Venue
The Lancet Oncology
Topic
Retraction
Abstract
Evidence source
Study design
Label agreement
Label status

Direct Codex and Gemma labels are unvalidated and sparse. Distilled predictions cover the full frame and are also unvalidated. Choose the evidence source explicitly; absence of a direct label is never a negative label.

affaffiliation
fundfunder
venuejournal
aboutaboutness

The four routes compose: require the funder route and exclude affiliation to get the funder-only stratum no affiliation-based frame ever sees.

832 results · 1 filter active ·
Results by year
20002025
Publication date
Categories
Machine labels · sparse coverage
Evidence
Language
Type
Citations
An unlabeled work is unknown, not a negative. Label coverage is reported on every query.
832 works in the cohort · of 4,299,418page 14 of 17

Labels cover 9 of 832 works in this cohort. The rest are unlabeled, which is not a negative label: the label table is sparse today and grows as labeling rounds land.

Distilled predictions cover 832 of 832 works in this cohort. Predictions are machine_predicted_unvalidated. The Gemma side is a direct model label for every work (title-only); the Codex side is a distilled, calibrated classifier. Candidate is the union; consensus is the intersection.

affaboutno abstractunlabeled
Transforming Canada's role in global cancer control
Danielle Rodin, Anna Dare, Reanne Booker, Christopher M. Booth, Heather Bryant, Ophira Ginsburg +7 more
2021· review· en· The Lancet Oncology· Medicine
machine prediction:candidate · noneconsensus · none
8
citations
affno abstractunlabeled
Fewer than three doses of HPV vaccine
Mark Jit, Jean‐François Laprise, Yoon Hong Choi, Marc Brisson
2015· letter· en· The Lancet Oncology· Medicine
machine prediction:candidate · noneconsensus · none
8
citations
affno abstractunlabeled
Metformin for pancreatic cancer
Kyaw Aung, Malcolm J. Moore
2015· letter· en· The Lancet Oncology· Biochemistry, Genetics and Molecular Biology
machine prediction:candidate · noneconsensus · none
7
citations
affno abstractunlabeled
The five Rs of chemotherapy
Ian F. Tannock
2016· article· en· The Lancet Oncology· Medicine
machine prediction:candidate · noneconsensus · none
7
citations
affno abstractunlabeled
The price function of toxicity
Mark Vincent, George Dranitsaris
2009· article· en· The Lancet Oncology· Economics, Econometrics and Finance
machine prediction:candidate · noneconsensus · none
6
citations
affno abstractunlabeled
First-line talazoparib plus enzalutamide versus placebo plus enzalutamide in men with metastatic castration-resistant prostate cancer and homologous recombination repair gene alterations: patient-reported outcomes from the randomised, double-blind, placebo-controlled, phase 3 TALAPRO-2 trial
André P. Fay, Karim Fizazi, Nobuaki Matsubara, Arun Azad, Fred Saad, Ugo De Giorgi +13 more
2025· article· en· The Lancet Oncology· Medicine
machine prediction:candidate · noneconsensus · none
6
citations
affno abstractunlabeled
A critique of the fragility index – Authors' reply
Joseph C. Del Paggio, Ian F. Tannock
2019· letter· en· The Lancet Oncology· Economics, Econometrics and Finance
machine prediction:candidate · metaresearchconsensus · none
6
citations
fundno affno abstractunlabeled
Drug repurposing in oncology
Gauthier Bouche, Craig Gedye, Lydie Meheus, Pan Pantziarka
2020· letter· en· The Lancet Oncology· Computer Science
machine prediction:candidate · noneconsensus · none
5
citations
affaboutno abstractunlabeled
Cancer patterns in Inuit populations
Barbara M. Young
2008· letter· en· The Lancet Oncology· Medicine
machine prediction:candidate · noneconsensus · none
5
citations
affno abstractunlabeled
Complications of prostate cancer treatment
Ross Halperin, Benjamin Maas, Tom Pickles
2014· letter· en· The Lancet Oncology· Medicine
machine prediction:candidate · noneconsensus · none
5
citations
affno abstractunlabeled
ChIPing away at breast cancer
Luca Magnani, Jason S. Carroll, Wilbert Zwart, Carlo Palmieri
2012· article· en· The Lancet Oncology· Biochemistry, Genetics and Molecular Biology
machine prediction:candidate · noneconsensus · none
4
citations
affno abstractunlabeled
Accelerating progress on EU cancer control
Andreas Charalambous, Richard Price, Prabhat Jha
2024· article· en· The Lancet Oncology· Medicine
machine prediction:candidate · noneconsensus · none
4
citations
affno abstractunlabeled
Recommendations for breast cancer screening
Martin J. Yaffe, Paula B. Gordon, Michael N. Linver
2020· letter· en· The Lancet Oncology· Medicine
machine prediction:candidate · noneconsensus · none
4
citations

How this was built: Screen · Findings · About